These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Modulation of ATPase activity by cholesterol and synthetic ether lipids in leukemic cells. Diomede L; Bianchi R; Modest EJ; Piovani B; Bubba F; Salmona M Biochem Pharmacol; 1992 Feb; 43(4):803-7. PubMed ID: 1311590 [TBL] [Abstract][Full Text] [Related]
4. Neoplastic cell inhibition with new ether lipid analogs. Noseda A; Berens ME; Piantadosi C; Modest EJ Lipids; 1987 Nov; 22(11):878-83. PubMed ID: 3444381 [TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis in human leukemic cells by the ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine. A possible basis for its selective action. Diomede L; Colotta F; Piovani B; Re F; Modest EJ; Salmona M Int J Cancer; 1993 Jan; 53(1):124-30. PubMed ID: 8416196 [TBL] [Abstract][Full Text] [Related]
6. Effects of antineoplastic ether lipids on model and biological membranes. Noseda A; Godwin PL; Modest EJ Biochim Biophys Acta; 1988 Nov; 945(1):92-100. PubMed ID: 3179313 [TBL] [Abstract][Full Text] [Related]
7. Accumulation of an alkyl lysophospholipid in tumor cell membranes affects membrane fluidity and tumor cell invasion. van Blitterswijk WJ; Hilkmann H; Storme GA Lipids; 1987 Nov; 22(11):820-3. PubMed ID: 3444372 [TBL] [Abstract][Full Text] [Related]
8. The induction of apoptosis is a common feature of the cytotoxic action of ether-linked glycerophospholipids in human leukemic cells. Diomede L; Piovani B; Re F; Principe P; Colotta F; Modest EJ; Salmona M Int J Cancer; 1994 Jun; 57(5):645-9. PubMed ID: 8194871 [TBL] [Abstract][Full Text] [Related]
9. Influence of serum levels on leukemic cell destruction by the ether lipid ET-18-OCH3. Heesbeen EC; Rijksen G; van Heugten HG; Verdonck LF Leuk Res; 1995 Jun; 19(6):417-25. PubMed ID: 7596155 [TBL] [Abstract][Full Text] [Related]
10. Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species. Wagner BA; Buettner GR; Oberley LW; Burns CP Cancer Res; 1998 Jul; 58(13):2809-16. PubMed ID: 9661895 [TBL] [Abstract][Full Text] [Related]
11. Membrane lipid modification and sensitivity of leukemic cells to the thioether lipid analogue BM 41.440. Petersen ES; Kelley EE; Modest EJ; Burns CP Cancer Res; 1992 Nov; 52(22):6263-9. PubMed ID: 1423272 [TBL] [Abstract][Full Text] [Related]
12. Induction of resistance in the human leukemia cell line HL60 towards hexadecylphosphocholine and other ether phospholipid analogues. Berkovic D; Haase D; Hiddemann W; Fleer EA J Exp Ther Oncol; 1996 Nov; 1(6):368-75. PubMed ID: 9414427 [TBL] [Abstract][Full Text] [Related]
13. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine. Chabot MC; Wykle RL; Modest EJ; Daniel LW Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333 [TBL] [Abstract][Full Text] [Related]
14. Effect of dietary lipids on plasma lipoproteins and fluidity of lymphoid cell membranes in normal and leukemic mice. Damen J; De Widt J; Hilkmann H; Van Blitterswijk WJ Biochim Biophys Acta; 1988 Aug; 943(2):166-74. PubMed ID: 3401476 [TBL] [Abstract][Full Text] [Related]
15. V-ATPase inhibition increases cancer cell stiffness and blocks membrane related Ras signaling - a new option for HCC therapy. Bartel K; Winzi M; Ulrich M; Koeberle A; Menche D; Werz O; Müller R; Guck J; Vollmar AM; von Schwarzenberg K Oncotarget; 2017 Feb; 8(6):9476-9487. PubMed ID: 28036299 [TBL] [Abstract][Full Text] [Related]
16. The effect of culture medium composition on ether lipid cytotoxic activity. Diomede L; Piovani B; Modest EJ; Salmona M Lipids; 1993 Mar; 28(3):189-92. PubMed ID: 8464349 [TBL] [Abstract][Full Text] [Related]
17. Ether lipids and derivatives as investigational anticancer drugs. A brief review. Berdel WE Onkologie; 1990 Aug; 13(4):245-50. PubMed ID: 2234777 [TBL] [Abstract][Full Text] [Related]
18. Role of membrane lipids in the interaction of daunomycin with plasma membranes from tumor cells: implications in drug-resistance phenomena. Escriba PV; Ferrer-Montiel AV; Ferragut JA; Gonzalez-Ros JM Biochemistry; 1990 Aug; 29(31):7275-82. PubMed ID: 2207106 [TBL] [Abstract][Full Text] [Related]
19. Influence of the bilayer composition on the binding and membrane disrupting effect of Polybia-MP1, an antimicrobial mastoparan peptide with leukemic T-lymphocyte cell selectivity. dos Santos Cabrera MP; Arcisio-Miranda M; Gorjão R; Leite NB; de Souza BM; Curi R; Procopio J; Ruggiero Neto J; Palma MS Biochemistry; 2012 Jun; 51(24):4898-908. PubMed ID: 22630563 [TBL] [Abstract][Full Text] [Related]
20. [Phospholipid and cholesterol levels in the tumor cell plasma membranes with different sensitivity to doxorubicin]. Chekhun VF; Tryndiak VP; Todor IM; Mykhaĭlenko VM; Kondrychyn IH; Dovbeshko HI; Repnyts'ka OP; Kulyk HI Ukr Biokhim Zh (1999); 2003; 75(4):120-5. PubMed ID: 14681985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]